Dual-filament regulation of contraction in fast and slow human skeletal muscle fibres

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

December 31, 2028
Response Due
Active
Status

Opportunity Overview

Skeletal muscle weakness is a major feature of many muscle disorders, yet there are currently no effective treatments to restore muscle contractility. This lack of therapeutic options reflects a limited understanding of the molecular mechanisms that regulate contraction in human skeletal muscle.
Traditionally, muscle contraction is controlled by calcium-dependent activation of the thin filament: following electrical stimulation, calcium ions released from the sarcoplasmic reticulum bind to troponin, triggering structural changes that enable actin filaments to interact with myosin motors on the thick filament, producing force and movement. However, recent evidence indicates that the thick filament itself plays a fundamental regulatory role in contraction. Calcium-independent mechanisms within the myosin filament control the transition of myosin motors between OFF and ON states, regulating force generation. So far, these newly identified mechanisms have been characterised only in “fast-contracting” fibres in animal models, whereas little is known about the two main fibre types of human skeletal muscle, the “slow-contracting” type-1 and the fast type-2A fibres.
Our preliminary findings suggest that thick filament-based regulatory mechanisms operate differently in human muscle fibres compared to previously studied models. Disruption of these mechanisms is already implicated in sarcomere-based cardiomyopathies. Moreover, small molecules that modulate myosin motor ON/OFF transitions have recently been developed to treat those heart diseases, demonstrating the feasibility of pharmacologically restoring contractile function. Although these myosin modulators also target the slow myosin in skeletal muscle, their effects on skeletal muscle regulation, and their therapeutic potential in muscle disorders, remain largely unexplored.
The overarching aim of this project is to define the fundamental regulatory mechanisms controlling human skeletal muscle contractility, in both...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedDecember 31, 2025
Procurement stageActive solicitation
Response dueDecember 31, 2028
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.